CALL FOR ABSTRACTS — APHA's 2018 Annual Meeting & Expo
Meeting theme: Creating the Healthiest Nation: Health Equity Now
Submission Deadline: Tuesday, February 20, 2018
The Pharmacy Special Primary Interest Group (Pharmacy SPIG) invites abstracts that fit with the theme of the 2018 Annual Meeting "Health Equity Now" and with the Pharmacy SPIG's interest in advancing public health-pharmacy partnership, expanded access to care, and the value of pharmacy services and pharmacists.
Abstracts are welcomed for oral, poster, or roundtable presentations. Members are encouraged to submit abstracts that reflect quality science and align broadly with interests and values of the Pharmacy SPIG. After reviewers score abstracts, the program committee arranges highest ranking submissions into sessions organized by topic. We will try to honor preferences for oral, poster, or roundtable presentations.
IMPORTANT NOTE: APHA allows all members to designate a SPIG as part of their APHA membership. If you are not yet a Pharmacy SPIG member, please consider joining our community.
The following topics reflect both historical concerns and current focus areas of the Pharmacy SPIG. They are neither prescriptive nor exclusive. The Pharmacy SPIG supports and advocates for public health and pharmacy initiatives and policies that benefit regional and global at-risk communities, education, government, organizations, as well as promotes ethical drug development and equitable access to care,. Topics that fall within the broadly outlined categories below are encouraged for submission:
1. Creating the Healthiest Nation: Health Equity Now (e.g., pharmacistsâ research and programmatic activities conducted to identify factors associated with and methods to address health inequities in chronic and infectious diseases; focus should be on social determinants of health)
2. Partnerships (e.g.,public health-pharmacy collaborations; clinical-community linkages; Pharmacistsâ impacts on essential health services; expanded access to care through pharmacy participation on the care team; transitions in care; partnership with health departments, FQHCs, and ACOs)
3. Pharmacy Policy, Economics, Quality, and Advocacy (e.g., assuring that national and global policies promote public health values; assure that the public health goals are addressed in pharmaceutical economics, such as drug pricing, Medicare, Medicaid; evaluation of outcomes of pharmacy services; pharmacoeconomics; health outcomes; prescription drug misuse and abuse; quality in medication use: patient safety, medication errors, advocacy, and programs and policies that relate to pharmacy)
4. Education (e.g., inter-professional education in public health; Introductory and Advance Pharmacy Practice Experiences in public health practice; integration of clinical prevention and population health into the curriculum; value of MPH/PharmD dual degree programs; outcomes of public health programming in PharmD curriculum; global health; expanding opportunities for diversity; addressing underserved communities)
We also welcome abstract submissions on other pharmacy or pharmacists-related subjects. Presentation proposals on topics such as pharmacy education, advocacy, public health practice activities, history, access to care, among others.
Abstracts submitted for consideration should reflect new information. Abstracts are limited to 250 words and should not contain charts, figures, etc. Abstracts should adequately describe the content and focus of the proposed presentation and follow the general outline of background, methods, results, and conclusions.
In addition to your abstract, you will be asked to provide the following information as part of the online submission process:
Learning Objectives: At least two measurable learning objectives are needed as a standing APHA requirement. The learning objectives are not included in the word count. Learning objectives must clearly identify the intended outcomes participants will be able to demonstrate as a result of attending/participating in your presentation. Verbs that cannot be clearly demonstrated (understand, learn, etc.) do not meet this criterion. Per APHA, learning objectives MUST include one of the following demonstrable verbs: explain, demonstrate, analyze, formulate, discuss, compare, differentiate, describe, name, assess, evaluate, identify, design, define or list. Each learning objective should be listed separately and numbered sequentially. Compound learning objectives (those containing more than one verb) are not permitted. For more information, please see: http://apha.confex.com/apha/learningobjectives.htm
Relevant Keywords: Keywords assist program planners in developing cohesive sessions and in assigning your abstract for blind peer-review. Please select only the keywords that best reflect the primary focus of your abstract submission. If the keyword options in the drop-down menu do not adequately reflect your content, please list your keywords in “Comments to Organizers.”
Preferred Presentation Format: You may select oral, poster, or either. Please note other preferences in the “Comments to Organizers.” Program planners will try to honor, but cannot guarantee, preference requests.
Qualifications Statement: You must include a brief (1 - 3 sentences) statement regarding why you are qualified to present on the content of your abstract. Statements should be tailored to the content, rather than generic statements related to education, training, or employment.
Conflict of Interest Disclosure: APHA requires presenters to disclose “any relevant personal financial relationship with a commercial entity that benefits the individual and may ultimately bias the presentation of that content.” The policy may be viewed at http://apha.confex.com/apha/disclosurepolicy.pdf
All abstracts are reviewed using a blind peer-review process. Incomplete abstracts or those failing to meet guidelines established by APHA will NOT be reviewed. View additional information regarding abstract submission guidelines at the following URL: http://apha.confex.com/apha/145am/intro.html (not open, yet).
NOTE: Submission of an abstract implies a commitment to make the presentation at the annual meeting. Presenters of accepted abstracts must be, or become, members of APHA and must be registered by the early-bird deadline.
Program Planner Contact Information:
Barry A. Bleidt, PhD, PharmD, RPh, FAPhA, FNPhA Sociobehavioral and Administrative Pharmacy Department Nova Southeastern University College of Pharmacy 3200 South University Drive Fort Lauderdale, FL 33328-2018 Phone: 954-262-1855 email@example.com